We are live on ! Find out more
KA

Kozak & Associates Portfolio holdings

AUM $576M
1-Year Est. Return 23.37%
This Fund
S&P 500
This Quarter Est. Return
-5.9%
1 Year Est. Return
+23.37%
3 Year Est. Return
+97.43%
5 Year Est. Return
+117.62%
10 Year Est. Return
–
AUM
$156M
AUM Growth
$0
Cap. Flow
-$113K
Cap. Flow %
-0.07%
Top 10 Hldgs %
71.02%
Holding
388
New
1
Increased
–
Reduced
4
Closed
1

Top Buys

Rank Stock Value
1
SHEL icon
Shell
SHEL
+$584K

Top Sells

Rank Stock Value
1
SCHA icon
Schwab U.S Small- Cap ETF
SCHA
+$99.7K
2
SCHG icon
Schwab US Large-Cap Growth ETF
SCHG
+$20.7K
3
SCHH icon
Schwab US REIT ETF
SCHH
+$5.12K
4
SCHX icon
Schwab US Large- Cap ETF
SCHX
+$2.71K

Sector Composition

Rank Sector Weight
1 Technology 11.23%
2 Consumer Discretionary 5.23%
3 Healthcare 4.38%
4 Financials 4.32%
5 Communication Services 3.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LLY icon
351
Eli Lilly
LLY
$1.06T
$2K ﹤0.01%
7
– –
SAIC icon
352
Saic
SAIC
$5.35B
$2K ﹤0.01%
21
– –
SNAP icon
353
Snap
SNAP
$9.01B
$2K ﹤0.01%
50
– –
TSN icon
354
Tyson Foods
TSN
$20.4B
$2K ﹤0.01%
21
– –
UPS icon
355
United Parcel Service
UPS
$88.9B
$2K ﹤0.01%
10
– –
VB icon
356
Vanguard Morningstar Small-Cap ETF
VB
$82.4B
$2K ﹤0.01%
8
– –
VONE icon
357
Vanguard Russell 1000 ETF
VONE
$8.58B
$2K ﹤0.01%
10
– –
XIFR
358
XPLR Infrastructure LP
XIFR
$1.08B
$2K ﹤0.01%
20
– –
TSP
359
DELISTED
TuSimple Holdings Inc. Class A Common Stock
TSP
$2K ﹤0.01%
181
– –
SDC
360
DELISTED
SmileDirectClub, Inc. Class A Common Stock
SDC
$2K ﹤0.01%
953
– –
CI icon
361
Cigna
CI
$74.6B
$1K ﹤0.01%
3
– –
CTVA icon
362
Corteva
CTVA
$51.3B
$1K ﹤0.01%
16
– –
DD icon
363
DuPont de Nemours
DD
$19.2B
$1K ﹤0.01%
13
– –
EMF
364
Templeton Emerging Markets Fund
EMF
$326M
$1K ﹤0.01%
110
– –
MUFG icon
365
Mitsubishi UFJ Financial
MUFG
$254B
$1K ﹤0.01%
130
– –
ONON icon
366
On Holding
ONON
$12.5B
$1K ﹤0.01%
28
– –
SDOG icon
367
ALPS Sector Dividend Dogs ETF
SDOG
$1.43B
$1K ﹤0.01%
27
– –
FIRY
368
Firy Inc
FIRY
$163M
$1K ﹤0.01%
23
– –
VEU icon
369
Vanguard FTSE All-World ex-US ETF
VEU
$68.5B
$1K ﹤0.01%
22
– –
VSS icon
370
Vanguard FTSE All-World ex-US Small-Cap Index Fund
VSS
$11.9B
$1K ﹤0.01%
8
– –
VTRS icon
371
Viatris
VTRS
$18.9B
$1K ﹤0.01%
88
– –
WAB icon
372
Wabtec
WAB
$49.3B
$1K ﹤0.01%
15
– –
WRAP icon
373
Wrap Technologies
WRAP
$104M
$1K ﹤0.01%
399
– –
DCP
374
DELISTED
DCP Midstream, LP
DCP
$1K ﹤0.01%
24
– –
BYND icon
375
Beyond Meat
BYND
$277M
$0 ﹤0.01%
1
– –
12 13 14
15
16

Similar funds

SCM
Simcoe Capital Management New York $576M AUM 36.22% 1-Year Est. Return
MIOT
Massachusetts Institute of Technology Cambridge, Massachusetts $577M AUM 8.5% 1-Year Est. Return
WCCM
Webs Creek Capital Management Dallas, Texas $578M AUM 79.84% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
AF
Aegis Financial Mc Lean, Virginia $580M AUM 105.74% 1-Year Est. Return
EHI
Eagle Health Investments Greenwich, Connecticut $572M AUM 67.49% 1-Year Est. Return
JCP
JB Capital Partners Armonk, New York $581M AUM 46.16% 1-Year Est. Return
MAM
McLean Asset Management Tysons, Virginia $572M AUM 22% 1-Year Est. Return

Kozak & Associates's Q1 2022 Portfolio in Review

As of Q1 2022, Kozak & Associates held 388 positions worth $156M, unchanged from the previous quarter. Its ten largest holdings account for 71% of the portfolio.

Trading was light in Q1 2022: portfolio turnover was 0.52%. Kozak & Associates opened 1 new position and exited 1, leaving the 388-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 11% of assets, unchanged from a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Kozak & Associates's largest Q1 2022 buy was Shell: 11,001 shares worth $569K.
  • Kozak & Associates's biggest Q1 2022 reduction was Schwab U.S Small- Cap ETF, cutting an estimated $99.7K.
  • Kozak & Associates's ten largest holdings make up 71% of its $156M portfolio in Q1 2022.
  • Kozak & Associates opened 1 new position and closed 1 in Q1 2022.
  • Kozak & Associates's portfolio value was unchanged quarter-over-quarter at $156M.

Based on Kozak & Associates's 13F filing for Q1 2022, filed 26 May 2022.